Author(s): Matta, Rosana da ; Borges, Jesse Lahos ; Landi, Ulisses Nilo ; Barbosa, Lidiane Nunes ; Lara, Amandha ; Otutumi, Luciana Kazue ; Ferraudo, Antonio Sergio [UNESP] ; Goncalves, Daniela Dib
Date: 2021
Persistent ID: http://hdl.handle.net/11449/210715
Origin: Oasisbr
Subject(s): Phytotherapy; Maternal Health; Integral assistance to health; Pharmaceutical care; Infant mortality; Patients 'safety
Made available in DSpace on 2021-06-26T03:35:35Z (GMT). No. of bitstreams: 0 Previous issue date: 2021-01-01
UNIPAR
Department of Health of the municipality of Umuarama/PR
The objective of this study was to examine the profile of pregnant women who visited the Unified Health System of the municipality of Umuarama'PR and to analyze their use of drugs categorized as D and X according to the United States Food and Drug Administration FDA and contraindicated medicinal plants for evaluating the potential gestational risks. A cross-sectional ethnoepidemiological study using a questionnaire was conducted among 500 pregnant women from January to May 2017. According to the pregnant women, during the prenatal period, 67.8% did not receive information on the use of medicinal plants and 26.6% used contraindicated plants. Among the drugs used, 12.2% belonged to category D (anticonvulsants), and 2.4% belonged to category X (hormonal contraceptives). This work highlights the need to expand health promotion activities to the basic units and implement protocols and technical guidance tools as well as training of pharmaceutical professionals to educate the population on the risk of these drugs during pregnancy.
Univ Paranaense, Programa Posgrad Plantas Med & Fitoterap Atencao, Umuarama, Parana, Brazil
Univ Paranaense, Programa Posgrad Ciencia Anim Enfase Prod Bioact, Umuarama, Parana, Brazil
Univ Estadual Paulista, Fac Ciencias Agr & Vet, Jaboticabal, SP, Brazil
Univ Estadual Paulista, Fac Ciencias Agr & Vet, Jaboticabal, SP, Brazil
